EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells

Marta Serafini iD, Sophie A Twigger, George Delfas, Maxim Mallerman, Elliot P Bailey, Ewen D D Calder iD, Ester M Hammond iD, Stuart J Conway iD

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.5c10240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Marta Serafini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K. Hauptthemen laut MEDLINE: Proteolysis, Cell Cycle Proteins, Transcription Factors, Indolequinones. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Medical Research Council, HORIZON EUROPE European Innovation Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisCell Cycle ProteinsTranscription FactorsIndolequinonesHumansCell Line, TumorVon Hippel-Lindau Tumor Suppressor ProteinUbiquitin-Protein LigasesCell HypoxiaProteolysis Targeting ChimeraBromodomain Containing ProteinsAdaptor Proteins, Signal Transducing

Substanzen

BRD4 protein, humanCell Cycle ProteinsTranscription FactorsIndolequinonesVon Hippel-Lindau Tumor Suppressor ProteinCRBN protein, humanVHL protein, humanUbiquitin-Protein LigasesProteolysis Targeting ChimeraBromodomain Containing Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford OX1 3TA, U.K.
  • Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.
  • Department of Chemistry & Biochemistry, University of California Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
  • California NanoSystems Institute, University of California Los Angeles, 570 Westwood Plaza, Building 114, Los Angeles, California 90095, United States.
  • Jonsson Comprehensive Cancer Center, University of California Los Angeles, 8-684 Factor Building, Los Angeles, California 90095, United States.
  • Molecular Biology Institute, University of California Los Angeles, 611 Charles E. Young Drive East, Los Angeles, California 90095, United States.

ORCID-Profile: Marta Serafini, Ewen D D Calder, Ester M Hammond, Stuart J Conway

Förderung

  • Engineering and Physical Sciences Research Council
  • Medical Research Council
  • HORIZON EUROPE European Innovation Council
  • University of California, Los Angeles
  • Corpus Christi College, University of Cambridge
  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Serafini, M., Twigger, S. A., Delfas, G., Mallerman, M., Bailey, E. P., Calder, E. D. D., Hammond, E. M., & Conway, S. J. (2025). Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c10240

Vancouver

Serafini M, Twigger SA, Delfas G, Mallerman M, Bailey EP, Calder EDD, et al. Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c10240

BibTeX
@article{Serafini2025,
  author = {Serafini, Marta and Twigger, Sophie A and Delfas, George and Mallerman, Maxim and Bailey, Elliot P and Calder, Ewen D D and Hammond, Ester M and Conway, Stuart J},
  title = {Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.5c10240}
}
Kostenlos starten →